Cited by 10Gene expression and cancer classificationBioinformatics and Genomic NetworksBreast Cancer Treatment Studies

Applications of gene pair methods in clinical research: advancing precision medicine

Open access
Wu, Changchun, Xie, Xueqin, Yang, Xin, Du, Mengze, Lin, Hao, Huang, Jian·2025·Molecular Biomedicine

Abstract

The rapid evolution of high-throughput sequencing technologies has revolutionized biomedical research, producing vast amounts of gene expression data that hold immense potential for biological discovery and clinical applications. Effectively mining these large-scale, high-dimensional data is crucial for facilitating disease detection, subtype differentiation, and understanding the molecular mechanisms underlying disease progression. However, the conventional paradigm of single-gene profiling, measuring absolute expression levels of individual genes, faces critical limitations in clinical implementation. These include vulnerability to batch effects and platform-dependent normalization requirements. In contrast, emerging approaches analyzing relative expression relationships between gene pairs demonstrate unique advantages. By focusing on binary comparisons of two genes’ expression magnitudes, these methods inherently normalize experimental variations while capturing biologically stable interaction patterns. In this review, we systematically evaluate gene pair-based analytical frameworks. We classify eleven computational approaches into two fundamental categories: expression value-based methods quantifying differential expression patterns, and rank-based methods exploiting transcriptional ordering relationships. To bridge methodological development with practical implementation, we establish a reproducible analytical pipeline incorporating feature selection, classifier construction, and model evaluation modules using real-world benchmark datasets from pulmonary tuberculosis studies. These findings position gene pair analysis as a transformative paradigm for mining high-dimensional omics data, with direct implications for precision biomarker discovery and mechanistic studies of disease progression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s43556-025-00263-w

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Traditional ML algorithms have been the cornerstone of early AI-assisted diagnostic models, particularly demonstrating robust performance in scenarios where features are well defined and sample sizes are moderate.

    “Traditional ML algorithms have been the cornerstone of early AI-assisted diagnostic models [106–110], particularly demonstrating robust performance in scenarios where features are well defined and sample sizes are moderate.”

    From Artificial intelligence-powered prediction of diabetic complications: from clinical data to molecular omics (2026) · cites this paper as [107]

    The sections on Relative Expression Orderings + Machine Learning and Top-Scoring Pair + Machine Learning describe diagnostic applications using conventional ML algorithms, including a model with promising predictive performance. They do not establish that traditional ML was the cornerstone of early AI-assisted diagnosis or that its performance is particularly robust when features are well defined and sample sizes moderate. The cited paper discusses the narrower setting of gene-pair methods. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 222

  1. [1]Guo Y, Ju Y, Chen D, Wang L. Research on the computational prediction of essential genes. Front Cell Dev Biol. 2021;9: 803608. 10.3389/fcell.2021.803608. 34938741 PMC8685449 · DOI
  2. [2]Mills MC, Tropf FC, Brazel DM, van Zuydam N, Vaez A, Consortium e, et al. Identification of 371 genetic variants for age at first sex and birth linked to externalising behaviour. Nat Hum Behav. 2021;5(12):1717–30. 10.1038/s41562-021-01135-3. PMC7612120 34211149 · DOI
  3. [5]Reuter JA, Spacek DV, Snyder MP. High-throughput sequencing technologies. Mol Cell. 2015;58(4):586–97. 10.1016/j.molcel.2015.05.004. 26000844 PMC4494749 · DOI
  4. [6]Heller MJ. DNA microarray technology: devices, systems, and applications. Annu Rev Biomed Eng. 2002;4(Volume 4, 2002):129–53. 10.1146/annurev.bioeng.4.020702.153438. 12117754 · DOI
  5. [7]Chee M, Yang R, Hubbell E, Berno A, Huang XC, Stern D, et al. Accessing genetic information with high-density DNA arrays. Science. 1996;274(5287):610–4. 10.1126/science.274.5287.610. 8849452 · DOI
  6. [8]Liu P, Li H, Liao C, Tang Y, Li M, Wang Z, et al. Identification of key genes and biological pathways in Chinese lung cancer population using bioinformatics analysis. PeerJ. 2022;10: e12731. 10.7717/peerj.12731. 35178291 PMC8812315 · DOI
  7. [9]Jacob L, Witteveen A, Beumer I, Delahaye L, Wehkamp D, van den Akker J, et al. Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial. Commun Biol. 2020;3(1):397. 10.1038/s42003-020-1111-1. 32719399 PMC7385160 · DOI
  8. [10]Grancharova T, Gerbin KA, Rosenberg AB, Roco CM, Arakaki JE, DeLizo CM, et al. A comprehensive analysis of gene expression changes in a high replicate and open-source dataset of differentiating hiPSC-derived cardiomyocytes. Sci Rep. 2021;11(1):15845. 10.1038/s41598-021-94732-1. 34349150 PMC8338992 · DOI · Paper page
  9. [11]Ullah R, Naz A, Akram HS, Ullah Z, Tariq M, Mithani A, et al. Transcriptomic analysis reveals differential gene expression, alternative splicing, and novel exons during mouse trophoblast stem cell differentiation. Stem Cell Res Ther. 2020;11(1):342. 10.1186/s13287-020-01848-8. 32762732 PMC7409654 · DOI
  10. [12]Mei F, Wang J, Chen Z, Yuan Z. Potentially important MicroRNAs in form-deprivation myopia revealed by bioinformatics analysis of MicroRNA profiling. Ophthalmic Res. 2017;57(3):186–93. 10.1159/000452421. 28190007 · DOI
  11. [13]Koizumi K, Oku M, Hayashi S, Inujima A, Shibahara N, Chen L, et al. Suppression of dynamical network biomarker signals at the predisease state (Mibyou) before metabolic syndrome in mice by a traditional Japanese medicine (Kampo Formula) Bofutsushosan. Evid Based Complement Alternat Med. 2020;2020: 9129134. 10.1155/2020/9129134. 32831883 PMC7424500 · DOI
  12. [14]Lee DY, Hah JH, Jeong WJ, Chung EJ, Kwon TK, Ahn SH, et al. The expression of defensin-associated genes may be correlated with lymph node metastasis of early-stage tongue cancer. Clin Exp Otorhinolaryngol. 2022;15(4):372–9. 10.21053/ceo.2022.00150. 36097842 PMC9723293 · DOI
  13. [15]Xu X, Zhang Y, Williams J, Antoniou E, McCombie WR, Wu S, et al. Parallel comparison of Illumina RNA-Seq and Affymetrix microarray platforms on transcriptomic profiles generated from 5-aza-deoxy-cytidine treated HT-29 colon cancer cells and simulated datasets. BMC Bioinformatics. 2013;14 Suppl 9(Suppl 9):S1. 10.1186/1471-2105-14-S9-S1. 23902433 PMC3697991 · DOI
  14. [16]Li T-H, Qin C, Zhao B-B, Cao H-T, Yang X-Y, Wang Y-Y, et al. Identification METTL18 as a potential prognosis biomarker and associated with immune infiltrates in hepatocellular carcinoma. Front Oncol. 2021;11: 665192. 10.3389/fonc.2021.665192. 34123827 PMC8187872 · DOI
  15. [17]Zhang G, Yang P. Bioinformatics genes and pathway analysis for chronic neuropathic pain after spinal cord injury. Biomed Res Int. 2017;2017: 6423021. 10.1155/2017/6423021. 29164149 PMC5661087 · DOI
  16. [18]Abid F, Rubab Z, Fatima S, Qureshi A, Azhar A, Jafri A. In-silico analysis of interacting pathways through KIM-1 protein interaction in diabetic nephropathy. BMC Nephrol. 2022;23(1):254. 10.1186/s12882-022-02876-7. 35843953 PMC9290293 · DOI
  17. [19]Fernández-Pérez L, Guerra B, Recio C, Cabrera-Galván JJ, García I, De La Rosa JV, et al. Transcriptomic and lipid profiling analysis reveals a functional interplay between testosterone and growth hormone in hypothyroid liver. Front endocrinol. 2023;14: 1266150. 10.3389/fendo.2023.1266150. PMC10748415 38144555 · DOI
  18. [20]Zhang L, Thapa I, Haas C, Bastola D. Multiplatform biomarker identification using a data-driven approach enables single-sample classification. BMC Bioinformatics. 2019;20(1):601. 10.1186/s12859-019-3140-7. 31752658 PMC6868758 · DOI
  19. [21]Liang E, Xiao S, Zhao C, Zhang Y, Fu G. M6A modification promotes blood-brain barrier breakdown during cerebral ischemia/reperfusion injury through increasing matrix metalloproteinase 3 expression. Heliyon. 2023;9(6): e16905. 10.1016/j.heliyon.2023.e16905. 37332938 PMC10275791 · DOI
  20. [22]Guan X, Hu R, Choi Y, Srivats S, Nabet BY, Silva J, et al. Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells. Nature. 2024;627(8004):646–55. 10.1038/s41586-024-07121-9. 38418879 PMC11139643 · DOI
  21. [23]Aiello G, Sabino C, Pernici D, Audano M, Antonica F, Gianesello M, et al. Transient rapamycin treatment during developmental stage extends lifespan in Mus musculus and Drosophila melanogaster. EMBO Rep. 2022;23(9):e55299. 10.15252/embr.202255299. 35796299 PMC9442325 · DOI
  22. [24]Dunsmore G, Rosero EP, Shahbaz S, Santer DM, Jovel J, Lacy P, et al. Neutrophils promote T-cell activation through the regulated release of CD44-bound Galectin-9 from the cell surface during HIV infection. PLoS Biol. 2021;19(8): e3001387. 10.1371/journal.pbio.3001387. 34411088 PMC8407585 · DOI
  23. [25]Wong HY, Sheng Q, Hesterberg AB, Croessmann S, Rios BL, Giri K, et al. Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease. Nat Commun. 2022;13(1):6036. 10.1038/s41467-022-33780-1. 36229464 PMC9562361 · DOI
  24. [26]Wang G, Hua R, Chen X, He X, Dingming Y, Chen H, et al. MX1 and UBE2L6 are potential metaflammation gene targets in both diabetes and atherosclerosis. PeerJ. 2024;12: e16975. 10.7717/peerj.16975. 38406276 PMC10893863 · DOI
  25. [27]Zhang Y, Luo Y, Liu X, Kiupel M, Li A, Wang H, et al. NCOA5 haploinsufficiency in myeloid-lineage cells sufficiently causes nonalcoholic steatohepatitis and hepatocellular carcinoma. Cell Mol Gastroenterol Hepatol. 2024;17(1):1–27. 10.1016/j.jcmgh.2023.09.007. 37734594 PMC10665956 · DOI
  26. [28]Yu H, Lin J, Yuan J, Sun X, Wang C, Bai B. Screening mitochondria-related biomarkers in skin and plasma of atopic dermatitis patients by bioinformatics analysis and machine learning. Front Immunol. 2024;15: 1367602. 10.3389/fimmu.2024.1367602. 38774875 PMC11106410 · DOI
  27. [29]Tabone O, Verma R, Singhania A, Chakravarty P, Branchett WJ, Graham CM, et al. Blood transcriptomics reveal the evolution and resolution of the immune response in tuberculosis. J Exp Med. 2021;218(10): e20210915. 10.1084/jem.20210915. 34491266 PMC8493863 · DOI
  28. [30]Sun J, Xie T, Jamal M, Tu Z, Li X, Wu Y, et al. CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment. Cancer Cell Int. 2020;20:106. 10.1186/s12935-020-01183-1. 32265595 PMC7110733 · DOI
  29. [31]Lee I-S, Ahn J, Kim K, Okugawa Y, Toiyama Y, Hur H, et al. A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer. Br J Cancer. 2021;125(6):846–53. 10.1038/s41416-021-01461-3. 34163003 PMC8437955 · DOI
  30. [32]Egan C, Nicolae A, Lack J, Chung H-J, Skarshaug S, Pham TA, et al. Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups. Haematologica. 2020;105(4):951–60. 10.3324/haematol.2019.230375. 31439678 PMC7109753 · DOI
  31. [33]Liu X, Wu L, Wang L, Li Y. Identification and classification of glioma subtypes based on RNA-binding proteins. Comput Biol Med. 2024;174: 108404. 10.1016/j.compbiomed.2024.108404. 38582000 · DOI
  32. [34]Liu X, Liu P, Chernock RD, Kuhs KAL, Lewis JS, Luo J, et al. A prognostic gene expression signature for oropharyngeal squamous cell carcinoma. EBioMedicine. 2020;61: 102805. 10.1016/j.ebiom.2020.102805. 33038770 PMC7648117 · DOI
  33. [35]Yang X, Lei P, Huang L, Tang X, Wei B, Wei H. Prognostic value of LRRC4C in colon and gastric cancers correlates with tumour microenvironment immunity. Int J Biol Sci. 2021;17(5):1413–27. 10.7150/ijbs.58876. 33867855 PMC8040466 · DOI
  34. [36]Shen Z, Du W, Perkins C, Fechter L, Natu V, Maecker H, et al. Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms. Cell Reports Medicine. 2021;2(10): 100425. 10.1016/j.xcrm.2021.100425. 34755136 PMC8561315 · DOI
  35. [37]Montalban-Bravo G, Class CA, Ganan-Gomez I, Kanagal-Shamanna R, Sasaki K, Richard-Carpentier G, et al. Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes. Leukemia. 2020;34(3):872–81. 10.1038/s41375-019-0623-5. 31719677 PMC7056563 · DOI
  36. [38]Zhang X, Yuan Z, Ji J, Li H, Xue F. Network or regression-based methods for disease discrimination: a comparison study. BMC Med Res Methodol. 2016;16:100. 10.1186/s12874-016-0207-2. 27538955 PMC4991108 · DOI
  37. [39]Zhang L, Ju T, Jin X, Ji J, Han J, Zhou X, et al. Network regression analysis for binary and ordinal categorical phenotypes in transcriptome-wide association studies. Genetics. 2022;222(4):iyac153. 10.1093/genetics/iyac153. 36227056 PMC9713396 · DOI
  38. [40]Eddy JA, Hood L, Price ND, Geman D. Identifying tightly regulated and variably expressed networks by Differential Rank Conservation (DIRAC). PLoS Comput Biol. 2010;6(5): e1000792. 10.1371/journal.pcbi.1000792. 20523739 PMC2877722 · DOI
  39. [41]Eddy JA, Sung J, Geman D, Price ND. Relative expression analysis for molecular cancer diagnosis and prognosis. Technol Cancer Res Treat. 2010;9(2):149–59. 10.1177/153303461000900204. 20218737 PMC2921829 · DOI
  40. [42]Bø TH, Jonassen I. New feature subset selection procedures for classification of expression profiles. Genome Biol. 2002;3(4):research0017.1-research.11. 11983058 PMC115205 · DOI
  41. [43]Dickinson SE, Griffin BA, Elmore MF, Kriese-Anderson L, Elmore JB, Dyce PW, et al. Transcriptome profiles in peripheral white blood cells at the time of artificial insemination discriminate beef heifers with different fertility potential. BMC Genomics. 2018;19(1):129. 10.1186/s12864-018-4505-4. 29426285 PMC5807776 · DOI
  42. [44]Vachani A, Nebozhyn M, Singhal S, Alila L, Wakeam E, Muschel R, et al. A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma. Clin Cancer Res. 2007;13(10):2905–15. 10.1158/1078-0432.CCR-06-1670. 17504990 · DOI
  43. [45]Zhong J, Huang Q, Wang Y, Gao H, Jia H, Fan J, et al. Distinguishing kawasaki disease from febrile infectious disease using gene pair signatures. Biomed Res Int. 2020;2020: 6539398. 10.1155/2020/6539398. 32420360 PMC7201505 · DOI
  44. [46]Yang BY, Sakharkar MK. Alterations in gene pair correlations as potential diagnostic markers for colon cancer. Int J Mol Sci. 2022;23(20): 12463. 10.3390/ijms232012463. 36293321 PMC9604343 · DOI
  45. [47]Li L, Wang B. One ferroptosis-related gene-pair signature serves as an original prognostic biomarker in lung adenocarcinoma. Front Genet. 2022;13: 841712. 10.3389/fgene.2022.841712. 35368652 PMC8965883 · DOI
  46. [48]Gordon GJ, Jensen RV, Hsiao L-L, Gullans SR, Blumenstock JE, Ramaswamy S, et al. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res. 2002;62(17):4963–7. 12208747
  47. [49]Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon LM, et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet. 2016;387(10035):2312–22. 10.1016/S0140-6736(15)01316-1. 27017310 PMC5392204 · DOI
  48. [50]Zhao S, Zhang B, Yang J, Zhou J, Xu Y. Linear discriminant analysis. Nat Rev Methods Primers. 2024;4(1):1–16. 10.1038/s43586-024-00346-y. · DOI
  49. [51]Lavi ES, Lin ZP, Ratner ES. Gene expression of non-homologous end-joining pathways in the prognosis of ovarian cancer. iScience. 2023;26(10):107934. 10.1016/j.isci.2023.107934. 37810216 PMC10558711 · DOI
  50. [52]Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, Mack D, et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci U S A. 1999;96(12):6745–50. 10.1073/pnas.96.12.6745. 10359783 PMC21986 · DOI
  51. [53]Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286(5439):531–7. 10.1126/science.286.5439.531. 10521349 · DOI · Paper page
  52. [54]Dysvik B, Jonassen I. J-Express: exploring gene expression data using Java. Bioinformatics. 2001;17(4):369–70. 10.1093/bioinformatics/17.4.369. 11301307 · DOI
  53. [55]Mukherjee S, Laiakis EC, Fornace AJ, Amundson SA. Impact of inflammatory signaling on radiation biodosimetry: mouse model of inflammatory bowel disease. BMC Genomics. 2019;20(1):329. 10.1186/s12864-019-5689-y. 31046668 PMC6498469 · DOI
  54. [56]Jeon H, Lee W, Park H, Lee HJ, Kim SK, Kim HB, et al. Automatic classification of tremor severity in parkinson’s disease using a wearable device. Sensors. 2017;17(9): 2067. 10.3390/s17092067. 28891942 PMC5621347 · DOI
  55. [57]Bianchini G, Pusztai L, Pienkowski T, Im Y-H, Bianchi GV, Tseng L-M, et al. Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial. Ann Oncol. 2015;26(12):2429–36. 10.1093/annonc/mdv395. 26387142 · DOI
  56. [58]Lai C, Reinders MJ, van’t Veer LJ, Wessels LF. A comparison of univariate and multivariate gene selection techniques for classification of cancer datasets. BMC Bioinformatics. 2006;7:235. 10.1186/1471-2105-7-235. PMC1569875 16670007 · DOI
  57. [59]Kanász R, Gnip P, Zoričák M, Drotár P. Bankruptcy prediction using ensemble of autoencoders optimized by genetic algorithm. PeerJ Comput Sci. 2023;9: e1257. 10.7717/peerj-cs.1257. 37346671 PMC10280414 · DOI
  58. [60]Ma X-J, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell. 2004;5(6):607–16. 10.1016/j.ccr.2004.05.015. 15193263 · DOI
  59. [61]Avissar M, Christensen BC, Kelsey KT, Marsit CJ. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res. 2009;15(8):2850–5. 10.1158/1078-0432.CCR-08-3131. 19351747 PMC2669849 · DOI
  60. [62]Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer. 2010;102(7):1174–9. 10.1038/sj.bjc.6605608. 20234369 PMC2853097 · DOI
  61. [63]Geman D, d’Avignon C, Naiman DQ, Winslow RL. Classifying gene expression profiles from pairwise mRNA comparisons. Stat Appl Genet Mol Biol. 2004;3:Article19. 10.2202/1544-6115.1071. 16646797 PMC1989150 · DOI
  62. [64]Tan AC, Naiman DQ, Xu L, Winslow RL, Geman D. Simple decision rules for classifying human cancers from gene expression profiles. Bioinformatics. 2005;21(20):3896–904. 10.1093/bioinformatics/bti631. 16105897 PMC1987374 · DOI
  63. [65]Xu L, Geman D, Winslow RL. Large-scale integration of cancer microarray data identifies a robust common cancer signature. BMC Bioinformatics. 2007;8:275. 10.1186/1471-2105-8-275. 17663766 PMC1950528 · DOI
  64. [66]Shi P, Ray S, Zhu Q, Kon MA. Top scoring pairs for feature selection in machine learning and applications to cancer outcome prediction. BMC Bioinformatics. 2011;12: 375. 10.1186/1471-2105-12-375. 21939564 PMC3223741 · DOI
  65. [67]Luo J, Xu P, Cao P, Wan H, Lv X, Xu S, et al. Integrating genetic and gene co-expression analysis identifies gene networks involved in alcohol and stress responses. Front Mol Neurosci. 2018;11: 102. 10.3389/fnmol.2018.00102. 29674951 PMC5895640 · DOI
  66. [68]Ao L, Zhang Z, Guan Q, Guo Y, Guo Y, Zhang J, et al. A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings. Liver Int. 2018;38(10):1812–9. 10.1111/liv.13864. 29682909 PMC6175149 · DOI
  67. [69]Zhang Z-M, Tan J-X, Wang F, Dao F-Y, Zhang Z-Y, Lin H. Early diagnosis of hepatocellular carcinoma using machine learning method. Front Bioeng Biotechnol. 2020;8: 254. 10.3389/fbioe.2020.00254. 32292778 PMC7122481 · DOI
  68. [70]West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A. 2001;98(20):11462–7. 10.1073/pnas.201162998. 11562467 PMC58752 · DOI
  69. [71]Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell. 2002;1(2):203–9. 10.1016/s1535-6108(02)00030-2. 12086878 · DOI
  70. [72]Miao Z, Humphreys BD, McMahon AP, Kim J. Multi-omics integration in the age of million single-cell data. Nat Rev Nephrol. 2021;17(11):710–24. 10.1038/s41581-021-00463-x. 34417589 PMC9191639 · DOI
  71. [73]Chen Y, Cai X, Cao Z, Lin J, Huang W, Zhuang Y, et al. Prediction of red blood cell transfusion after orthopedic surgery using an interpretable machine learning framework. Front Surg. 2023;10: 1047558. 10.3389/fsurg.2023.1047558. 36936651 PMC10017874 · DOI
  72. [74]Zhao H, Logothetis CJ, Gorlov IP, Zeng J, Dai J. Modified logistic regression models using gene coexpression and clinical features to predict prostate cancer progression. Comput Math Methods Med. 2013;2013: 917502. 10.1155/2013/917502. 24367394 PMC3866878 · DOI
  73. [75]Wang X. Robust two-gene classifiers for cancer prediction. Genomics. 2012;99(2):90–5. 10.1016/j.ygeno.2011.11.003. 22138042 PMC3273650 · DOI
  74. [76]Wang H, Zhang H, Dai Z, Chen MS, Yuan Z. TSG: a new algorithm for binary and multi-class cancer classification and informative genes selection. BMC Med Genomics. 2013;6 Suppl 1(Suppl 1):S3. 10.1186/1755-8794-6-S1-S3. 23445528 PMC3552704 · DOI
  75. [77]Moody L, Chen H, Pan Y-X. Considerations for feature selection using gene pairs and applications in large-scale dataset integration, novel oncogene discovery, and interpretable cancer screening. BMC Med Genomics. 2020;13(Suppl 10):148. 10.1186/s12920-020-00778-x. 33087122 PMC7579924 · DOI
  76. [78]Leek JT. The tspair package for finding top scoring pair classifiers in R. Bioinformatics. 2009;25(9):1203–4. 10.1093/bioinformatics/btp126. 19276151 PMC2672632 · DOI
  77. [79]Isella C, Brundu F, Bellomo SE, Galimi F, Zanella E, Porporato R, et al. Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer. Nat Commun. 2017;8: 15107. 10.1038/ncomms15107. 28561063 PMC5499209 · DOI
  78. [80]Hua Y, Cai D, Shirley CA, Mo S, Chen R, Gao F, et al. A prognostic model for ovarian neoplasms established by an integrated analysis of 1580 transcriptomic profiles. Sci Rep. 2023;13(1):19429. 10.1038/s41598-023-45410-x. 37940688 PMC10632395 · DOI
  79. [81]Zhao H, Logothetis CJ, Gorlov IP. Usefulness of the top-scoring pairs of genes for prediction of prostate cancer progression. Prostate Cancer Prostatic Dis. 2010;13(3):252–9. 10.1038/pcan.2010.9. 20386565 PMC4136464 · DOI
  80. [82]Weichselbaum RR, Ishwaran H, Yoon T, Nuyten DSA, Baker SW, Khodarev N, et al. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci U S A. 2008;105(47):18490–5. 10.1073/pnas.0809242105. 19001271 PMC2587578 · DOI
  81. [83]Raponi M, Lancet JE, Fan H, Dossey L, Lee G, Gojo I, et al. A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia. Blood. 2008;111(5):2589–96. 10.1182/blood-2007-09-112730. 18160667 · DOI
  82. [84]Qi L, Chen L, Li Y, Qin Y, Pan R, Zhao W, et al. Critical limitations of prognostic signatures based on risk scores summarized from gene expression levels: a case study for resected stage I non-small-cell lung cancer. Brief Bioinform. 2016;17(2):233–42. 10.1093/bib/bbv064. 26254430 · DOI
  83. [85]Lin X, Afsari B, Marchionni L, Cope L, Parmigiani G, Naiman D, et al. The ordering of expression among a few genes can provide simple cancer biomarkers and signal BRCA1 mutations. BMC Bioinformatics. 2009;10: 256. 10.1186/1471-2105-10-256. 19695104 PMC2745389 · DOI
  84. [86]Li C, Zhang B, Schaafsma E, Reuben A, Wang L, Turk MJ, et al. TimiGP: inferring cell-cell interactions and prognostic associations in the tumor immune microenvironment through gene pairs. Cell Reports Medicine. 2023;4(7): 101121. 10.1016/j.xcrm.2023.101121. 37467716 PMC10394258 · DOI
  85. [87]Lu M, Yin R, Chen XS. Ensemble methods of rank-based trees for single sample classification with gene expression profiles. J Transl Med. 2024;22(1):140. 10.1186/s12967-024-04940-2. 38321494 PMC10848444 · DOI
  86. [88]Czajkowski M, Jurczuk K, Kretowski M. Enhancing multi-omics data classification with relative expression analysis and decision trees. Journal of Computational Science. 2025;84: 102460. 10.1016/j.jocs.2024.102460. · DOI
  87. [89]Czajkowski M, Jurczuk K, Kretowski M. Enhancing transparency of omics data analysis with the evolutionary multi-test tree and relative expression. Expert Syst Appl. 2025;276: 127131. 10.1016/j.eswa.2025.127131. · DOI
  88. [90]Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 2002;415(6870):436–42. 10.1038/415436a. 11807556 · DOI
  89. [91]Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RCT, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 2002;8(1):68–74. 10.1038/nm0102-68. 11786909 · DOI
  90. [92]Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet. 2002;30(1):41–7. 10.1038/ng765. 11731795 · DOI
  91. [94]Zhang Z. Introduction to machine learning: k-nearest neighbors. Ann Transl Med. 2016;4(11):218. 10.21037/atm.2016.03.37. 27386492 PMC4916348 · DOI
  92. [95]Zhang Z. Naïve Bayes classification in R. Ann Transl Med. 2016;4(12):241. 10.21037/atm.2016.03.38. 27429967 PMC4930525 · DOI
  93. [96]Ferrarotto R, Mishra V, Herz E, Yaacov A, Solomon O, Rauch R, et al. AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling. Cell Death Dis. 2022;13(8):678. 10.1038/s41419-022-05133-9. 35931701 PMC9355983 · DOI
  94. [97]Pakula H, Omar M, Carelli R, Pederzoli F, Fanelli GN, Pannellini T, et al. Distinct mesenchymal cell states mediate prostate cancer progression. Nat Commun. 2024;15(1):363. 10.1038/s41467-023-44210-1. 38191471 PMC10774315 · DOI
  95. [98]Li B, Cui Y, Diehn M, Li R. Development and validation of an individualized immune prognostic signature in early-stage nonsquamous non-small cell lung cancer. JAMA Oncol. 2017;3(11):1529–37. 10.1001/jamaoncol.2017.1609. 28687838 PMC5710196 · DOI · Paper page
  96. [99]Liu S, Nalesnik MA, Singhi A, Wood-Trageser MA, Randhawa P, Ren B-G, et al. Transcriptome and exome analyses of hepatocellular carcinoma reveal patterns to predict cancer recurrence in liver transplant patients. Hepatology Communications. 2022;6(4):710–27. 10.1002/hep4.1846. 34725972 PMC8948579 · DOI
  97. [100]Price ND, Trent J, El-Naggar AK, Cogdell D, Taylor E, Hunt KK, et al. Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad Sci U S A. 2007;104(9):3414–9. 10.1073/pnas.0611373104. 17360660 PMC1805517 · DOI
  98. [101]Horr C, Buechler SA. Breast cancer consensus subtypes: a system for subtyping breast cancer tumors based on gene expression. NPJ breast cancer. 2021;7(1):136. 10.1038/s41523-021-00345-2. 34642313 PMC8511026 · DOI
  99. [102]Scialdone A, Natarajan KN, Saraiva LR, Proserpio V, Teichmann SA, Stegle O, et al. Computational assignment of cell-cycle stage from single-cell transcriptome data. Methods. 2015;85:54–61. 10.1016/j.ymeth.2015.06.021. 26142758 · DOI
  100. [103]Dihge L, Vallon-Christersson J, Hegardt C, Saal LH, Häkkinen J, Larsson C, et al. Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: development and validation within a population-based cohort. Clin Cancer Res. 2019;25(21):6368–81. 10.1158/1078-0432.CCR-19-0075. 31340938 · DOI
  101. [104]Omar M, Nuzzo PV, Ravera F, Bleve S, Fanelli GN, Zanettini C, et al. Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer. J Transl Med. 2023;21(1):811. 10.1186/s12967-023-04713-3. 37964363 PMC10647131 · DOI
  102. [105]Hochberg JT, Sohal A, Handa P, Maliken BD, Kim T-K, Wang K, et al. Serum miRNA profiles are altered in patients with primary sclerosing cholangitis receiving high-dose ursodeoxycholic acid. JHEP Rep. 2023;5(6): 100729. 10.1016/j.jhepr.2023.100729. 37179785 PMC10172698 · DOI
  103. [106]Afsari B, Fertig EJ, Geman D, Marchionni L. switchBox: an R package for k-Top Scoring Pairs classifier development. Bioinformatics. 2015;31(2):273–4. 10.1093/bioinformatics/btu622. 25262153 PMC4287945 · DOI
  104. [107]Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet. 2005;365(9458):488–92. 10.1016/S0140-6736(05)17866-0. 15705458 · DOI
  105. [108]Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A. 2001;98(26):15149–54. 10.1073/pnas.211566398. 11742071 PMC64998 · DOI
  106. [109]Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A. 2001;98(24):13790–5. 10.1073/pnas.191502998. 11707567 PMC61120 · DOI
  107. [110]Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L, et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol. 2004;22(14):2790–9. 10.1200/JCO.2004.05.158. 15254046 · DOI
  108. [111]Tsoi J, Robert L, Paraiso K, Galvan C, Sheu KM, Lay J, et al. Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress. Cancer Cell. 2018;33(5):890-904.e5. 10.1016/j.ccell.2018.03.017. 29657129 PMC5953834 · DOI · Paper page
  109. [112]Wang H, Sun Q, Zhao W, Qi L, Gu Y, Li P, et al. Individual-level analysis of differential expression of genes and pathways for personalized medicine. Bioinformatics. 2015;31(1):62–8. 10.1093/bioinformatics/btu522. 25165092 · DOI
  110. [113]Wei T-YW, Juan C-C, Hisa J-Y, Su L-J, Lee Y-CG, Chou H-Y, et al. Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade. Cancer Sci. 2012;103(9):1640–50. 10.1111/j.1349-7006.2012.02367.x. 22726390 PMC7659304 · DOI
  111. [114]Chen D-T, Nasir A, Culhane A, Venkataramu C, Fulp W, Rubio R, et al. Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue. Breast Cancer Res Treat. 2010;119(2):335–46. 10.1007/s10549-009-0344-y. 19266279 PMC2796276 · DOI
  112. [115]Song Q-S, Wu H-J, Lin Q, Tang Y-K. Identification of a seven autophagy-related gene pairs signature for the diagnosis of colorectal cancer using the RankComp algorithm. J Bioinform Comput Biol. 2023;21(3):2350012. 10.1142/S0219720023500129. 37325865 · DOI
  113. [116]Hu G, Cheng Z, Wu Z, Wang H. Identification of potential key genes associated with osteosarcoma based on integrated bioinformatics analyses. J Cell Biochem. 2019;120(8):13554–61. 10.1002/jcb.28630. 30920023 · DOI
  114. [117]Cai H, Li X, Li J, Liang Q, Zheng W, Guan Q, et al. Identifying differentially expressed genes from cross-site integrated data based on relative expression orderings. Int J Biol Sci. 2018;14(8):892–900. 10.7150/ijbs.24548. 29989020 PMC6036750 · DOI
  115. [118]Wang H, Cai H, Ao L, Yan H, Zhao W, Qi L, et al. Individualized identification of disease-associated pathways with disrupted coordination of gene expression. Brief Bioinform. 2016;17(1):78–87. 10.1093/bib/bbv030. 26023086 · DOI
  116. [119]Blanchet FG, Legendre P, Borcard D. Forward selection of explanatory variables. Ecology. 2008;89(9):2623–32. 10.1890/07-0986.1. 18831183 · DOI
  117. [120]Zhou Y-J, Lu X-F, Meng J-L, Wang X-Y, Ruan X-J, Yang C-J, et al. Qualitative transcriptional signature for the pathological diagnosis of pancreatic cancer. Front Mol Biosci. 2020;7: 569842. 10.3389/fmolb.2020.569842. 33173782 PMC7538791 · DOI
  118. [121]Wang O, Shi D, Li Y, Zhou X, Yan H, Yao Q. lncRNA pair as candidate diagnostic signature for colorectal cancer based on the within-sample relative expression levels. Front Oncol. 2022;12: 912882. 10.3389/fonc.2022.912882. 36059706 PMC9428707 · DOI
  119. [122]Yan H, Li M, Cao L, Chen H, Lai H, Guan Q, et al. A robust qualitative transcriptional signature for the correct pathological diagnosis of gastric cancer. J Transl Med. 2019;17(1):63. 10.1186/s12967-019-1816-4. 30819200 PMC6394047 · DOI
  120. [123]Bu X, Ma L, Liu S, Wen D, Kan A, Xu Y, et al. A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma. Cancer Cell Int. 2022;22(1):95. 10.1186/s12935-022-02507-z. 35193591 PMC8862507 · DOI
  121. [124]Li G, Xu W, Zhang L, Liu T, Jin G, Song J, et al. Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma. EBioMedicine. 2019;47:128–41. 10.1016/j.ebiom.2019.08.064. 31492561 PMC6796541 · DOI
  122. [125]Peng H, Long F, Ding C. Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy. IEEE Trans Pattern Anal Mach Intell. 2005;27(8):1226–38. 10.1109/TPAMI.2005.159. 16119262 · DOI
  123. [126]Li F, Li C, Wang M, Webb GI, Zhang Y, Whisstock JC, et al. GlycoMine: a machine learning-based approach for predicting N-, C- and O-linked glycosylation in the human proteome. Bioinformatics. 2015;31(9):1411–9. 10.1093/bioinformatics/btu852. 25568279 · DOI
  124. [128]Zhang Z-Y, Sun Z-J, Gao D, Hao Y-D, Lin H, Liu F. Excavation of gene markers associated with pancreatic ductal adenocarcinoma based on interrelationships of gene expression. IET Syst Biol. 2024;18(6):261–70. 10.1049/syb2.12090. 38530028 PMC11665842 · DOI
  125. [129]Li X, Ge J, Liu Z, Yang S, Wang L, Liu Y. Estimating the methane flux of the Dajiuhu subalpine peatland using machine learning algorithms and the maximal information coefficient technique. Sci Total Environ. 2024;916: 170241. 10.1016/j.scitotenv.2024.170241. 38278264 · DOI
  126. [130]Auliah FN, Nilamyani AN, Shoombuatong W, Alam MA, Hasan MM, Kurata H. PUP-Fuse: prediction of protein pupylation sites by integrating multiple sequence representations. Int J Mol Sci. 2021;22(4): 2120. 10.3390/ijms22042120. 33672741 PMC7924619 · DOI
  127. [131]Wang M, Perucho JAU, Vardhanabhuti V, Ip P, Ngan HYS, Lee EYP. Radiomic features of T2-weighted imaging and diffusion kurtosis imaging in differentiating clinicopathological characteristics of cervical carcinoma. Acad Radiol. 2022;29(8):1133–40. 10.1016/j.acra.2021.08.018. 34583867 · DOI
  128. [132]LaValley MP. Logistic regression. Circulation. 2008. 10.1161/CIRCULATIONAHA.106.682658. 18458181 · DOI
  129. [133]King RD, Orhobor OI, Taylor CC. Cross-validation is safe to use. Nat Mach Intell. 2021;3(4):276-. 10.1038/s42256-021-00332-z. · DOI
  130. [135]Clough E, Barrett T. The gene expression omnibus database. Methods Mol Biol. 2016;1418:93–110. 10.1007/978-1-4939-3578-9_5. 27008011 PMC4944384 · DOI
  131. [136]Berry MPR, Graham CM, McNab FW, Xu Z, Bloch SAA, Oni T, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 2010;466(7309):973–7. 10.1038/nature09247. 20725040 PMC3492754 · DOI · Paper page
  132. [137]Blankley S, Graham CM, Turner J, Berry MPR, Bloom CI, Xu Z, et al. The transcriptional signature of active tuberculosis reflects symptom status in extra-pulmonary and pulmonary tuberculosis. PLoS ONE. 2016;11(10): e0162220. 10.1371/journal.pone.0162220. 27706152 PMC5051928 · DOI
  133. [138]Joyce SM. Sputum analysis and culture. Ann Emerg Med. 1986;15(3):325–8. 10.1016/s0196-0644(86)80576-5. 3946881 · DOI
  134. [139]Campbell JR, Krot J, Elwood K, Cook V, Marra F. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants. Mol Diagn Ther. 2015;19(1):9–24. 10.1007/s40291-014-0125-0. 25579159 · DOI
  135. [140]Huebner RE, Schein MF, John B, Bass J. The tuberculin skin test. Clin Infect Dis. 1993;17(6):968–75. 8110954 · DOI
  136. [141]Lalvani A, Pareek M. Interferon gamma release assays: principles and practice. Enferm Infecc Microbiol Clin. 2010;28(4):245–52. 10.1016/j.eimc.2009.05.012. 19783328 · DOI
  137. [142]Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7): e47. 10.1093/nar/gkv007. 25605792 PMC4402510 · DOI · Paper page
  138. [143]Jobe D, Darboe F, Muefong CN, Barry A, Coker EG, Mohammed N, et al. Gene expression in TB disease measured from the periphery is different from the site of infection. Tuberculosis (Edinb). 2022;134: 102187. 10.1016/j.tube.2022.102187. 35316743 PMC9760103 · DOI
  139. [144]Natarajan S, Ranganathan M, Hanna LE, Tripathy S. Transcriptional profiling and deriving a seven-gene signature that discriminates active and latent tuberculosis: an integrative bioinformatics approach. Genes. 2022;13(4): 616. 10.3390/genes13040616. 35456421 PMC9032611 · DOI
  140. [145]Eckold C, Kumar V, Weiner J, Alisjahbana B, Riza A-L, Ronacher K, et al. Impact of intermediate hyperglycemia and diabetes on immune dysfunction in tuberculosis. Clin Infect Dis. 2021;72(1):69–78. 10.1093/cid/ciaa751. 32533832 PMC7823074 · DOI
  141. [146]Blankley S, Graham CM, Levin J, Turner J, Berry MPR, Bloom CI, et al. A 380-gene meta-signature of active tuberculosis compared with healthy controls. Eur Respir J. 2016;47(6):1873–6. 10.1183/13993003.02121-2015. 27076596 PMC4892351 · DOI
  142. [147]Kaforou M, Wright VJ, Oni T, French N, Anderson ST, Bangani N, et al. Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med. 2013;10(10): e1001538. 10.1371/journal.pmed.1001538. 24167453 PMC3805485 · DOI
  143. [149]Thakur C, Tripathi A, Ravichandran S, Shivananjaiah A, Chakraborty A, Varadappa S, et al. A new blood-based RNA signature (R9), for monitoring effectiveness of tuberculosis treatment in a South Indian longitudinal cohort. iScience. 2022;25(2):103745. 10.1016/j.isci.2022.103745. 35118358 PMC8800112 · DOI
  144. [150]Sutherland JS, Loxton AG, Haks MC, Kassa D, Ambrose L, Lee J-S, et al. Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity. Clin Microbiol Infect. 2014;20(4):O230–8. 10.1111/1469-0691.12383. 24205913 · DOI
  145. [151]Gebremicael G, Kassa D, Quinten E, Alemayehu Y, Gebreegziaxier A, Belay Y, et al. Host gene expression kinetics during treatment of tuberculosis in HIV-coinfected individuals is independent of highly active antiretroviral therapy. J Infect Dis. 2018;218(11):1833–46. 10.1093/infdis/jiy404. 29982697 · DOI
  146. [152]Sambarey A, Devaprasad A, Mohan A, Ahmed A, Nayak S, Swaminathan S, et al. Unbiased identification of blood-based biomarkers for pulmonary tuberculosis by modeling and mining molecular interaction networks. EBioMedicine. 2017;15:112–26. 10.1016/j.ebiom.2016.12.009. 28065665 PMC5233809 · DOI
  147. [153]Penn-Nicholson A, Mbandi SK, Thompson E, Mendelsohn SC, Suliman S, Chegou NN, et al. RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response. Sci Rep. 2020;10(1):8629. 10.1038/s41598-020-65043-8. 32451443 PMC7248089 · DOI
  148. [154]Esmail H, Lai RP, Lesosky M, Wilkinson KA, Graham CM, Horswell S, et al. Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis. Proc Natl Acad Sci U S A. 2018;115(5):E964–73. 10.1073/pnas.1711853115. 29339504 PMC5798330 · DOI
  149. [155]Hoang LT, Jain P, Pillay TD, Tolosa-Wright M, Niazi U, Takwoingi Y, et al. Transcriptomic signatures for diagnosing tuberculosis in clinical practice: a prospective, multicentre cohort study. Lancet Infect Dis. 2021;21(3):366–75. 10.1016/S1473-3099(20)30928-2. 33508221 PMC7907671 · DOI
  150. [156]Tetreault M-P, Yang Y, Katz JP. Krüppel-like factors in cancer. Nat Rev Cancer. 2013;13(10):701–13. 10.1038/nrc3582. 24060862 · DOI
  151. [157]Sweeney TE, Braviak L, Tato CM, Khatri P. Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. Lancet Respir Med. 2016;4(3):213–24. 10.1016/S2213-2600(16)00048-5. 26907218 PMC4838193 · DOI
  152. [158]Chang A, Loy CJ, Eweis-LaBolle D, Lenz JS, Steadman A, Andgrama A, et al. Circulating cell-free RNA in blood as a host response biomarker for detection of tuberculosis. Nat Commun. 2024;15(1):4949. 10.1038/s41467-024-49245-6. 38858368 PMC11164910 · DOI
  153. [159]Banafea O, Mghanga FP, Zhao J, Zhao R, Zhu L. Endoscopic ultrasonography with fine-needle aspiration for histological diagnosis of solid pancreatic masses: a meta-analysis of diagnostic accuracy studies. BMC Gastroenterol. 2016;16(1):108. 10.1186/s12876-016-0519-z. 27580856 PMC5007683 · DOI
  154. [160]Frampton AE, Castellano L, Colombo T, Giovannetti E, Krell J, Jacob J, et al. MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression. Gastroenterology. 2014;146(1):268-77.e18. 10.1053/j.gastro.2013.10.010. 24120476 · DOI
  155. [161]Sutaria DS, Jiang J, Azevedo-Pouly ACP, Lee EJ, Lerner MR, Brackett DJ, et al. Expression profiling identifies the noncoding processed transcript of HNRNPU with proliferative properties in pancreatic ductal adenocarcinoma. Non-coding RNA. 2017;3(3): 24. 10.3390/ncrna3030024. 29657295 PMC5831917 · DOI
  156. [162]Jiang J, Azevedo-Pouly ACP, Redis RS, Lee EJ, Gusev Y, Allard D, et al. Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma. Oncotarget. 2016;7(33):53165–77. 10.18632/oncotarget.10242. 27363020 PMC5288176 · DOI
  157. [163]Klett H, Fuellgraf H, Levit-Zerdoun E, Hussung S, Kowar S, Küsters S, et al. Identification and validation of a diagnostic and prognostic multi-gene biomarker panel for pancreatic ductal adenocarcinoma. Front Genet. 2018;9: 108. 10.3389/fgene.2018.00108. 29675033 PMC5895731 · DOI
  158. [164]Moffitt RA, Marayati R, Flate EL, Volmar KE, Loeza SGH, Hoadley KA, et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet. 2015;47(10):1168–78. 10.1038/ng.3398. 26343385 PMC4912058 · DOI · Paper page
  159. [165]Stratford JK, Bentrem DJ, Anderson JM, Fan C, Volmar KA, Marron JS, et al. A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma. PLoS Med. 2010;7(7): e1000307. 10.1371/journal.pmed.1000307. 20644708 PMC2903589 · DOI
  160. [166]Crnogorac-Jurcevic T, Chelala C, Barry S, Harada T, Bhakta V, Lattimore S, et al. Molecular analysis of precursor lesions in familial pancreatic cancer. PLoS ONE. 2013;8(1): e54830. 10.1371/journal.pone.0054830. 23372777 PMC3553106 · DOI
  161. [167]Rs Janky, Binda MM, Allemeersch J, Van den Broeck A, Govaere O, Swinnen JV, et al. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma. BMC Cancer. 2016;16:632. 10.1186/s12885-016-2540-6. 27520560 PMC4983037 · DOI
  162. [168]Hiraoka N, Yamazaki-Itoh R, Ino Y, Mizuguchi Y, Yamada T, Hirohashi S, et al. CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis. Gastroenterology. 2011;140(1):310–21. 10.1053/j.gastro.2010.10.009. 20955708 · DOI
  163. [169]Grimont A, Pinho AV, Cowley MJ, Augereau C, Mawson A, Giry-Laterrière M, et al. SOX9 regulates ERBB signalling in pancreatic cancer development. Gut. 2015;64(11):1790–9. 10.1136/gutjnl-2014-307075. 25336113 · DOI
  164. [170]Xu L, Tan AC, Naiman DQ, Geman D, Winslow RL. Robust prostate cancer marker genes emerge from direct integration of inter-study microarray data. Bioinformatics. 2005;21(20):3905–11. 10.1093/bioinformatics/bti647. 16131522 · DOI
  165. [171]Stuart RO, Wachsman W, Berry CC, Wang-Rodriguez J, Wasserman L, Klacansky I, et al. In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc Natl Acad Sci U S A. 2004;101(2):615–20. 10.1073/pnas.2536479100. 14722351 PMC327196 · DOI
  166. [172]Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 2001;61(16):5974–8. 11507037
  167. [173]Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A. 2004;101(3):811–6. 10.1073/pnas.0304146101. 14711987 PMC321763 · DOI
  168. [174]LaTulippe E, Satagopan J, Smith A, Scher H, Scardino P, Reuter V, et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 2002;62(15):4499–506. 12154061
  169. [175]Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin S-F, Dunning MJ, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 2007;8(10): R214. 10.1186/gb-2007-8-10-r214. 17922911 PMC2246288 · DOI
  170. [176]Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, Glazer C, et al. MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer. 2008;123(12):2791–7. 10.1002/ijc.23831. 18798260 PMC3184846 · DOI
  171. [177]Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834–8. 10.1038/nature03702. 15944708 · DOI
  172. [178]Hattori E, Oyama R, Kondo T. Systematic review of the current status of human sarcoma cell lines. Cells. 2019;8(2): 157. 10.3390/cells8020157. 30781855 PMC6406745 · DOI
  173. [179]Clary BM, DeMatteo RP, Lewis JJ, Leung D, Brennan MF. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison. Ann Surg Oncol. 2001;8(4):290–9. 10.1007/s10434-001-0290-3. 11352301 · DOI
  174. [180]Fletcher CDM, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol. 2002;33(5):459–65. 10.1053/hupa.2002.123545. 12094370 · DOI
  175. [181]Fan J, Chen M, Cao S, Yao Q, Zhang X, Du S, et al. Identification of a ferroptosis-related gene pair biomarker with immune infiltration landscapes in ischemic stroke: a bioinformatics-based comprehensive study. BMC Genomics. 2022;23:59. 10.1186/s12864-022-08295-0. 35033021 PMC8761271 · DOI
  176. [182]Buhmann MD. Radial basis functions. Acta Numer. 2000;9:1–38. 10.1017/S0962492900000015. · DOI
  177. [183]Liberty E, Lang K, Shmakov K, editors. Stratified sampling meets machine learning. International conference on machine learning. 2016. 2016-06-11: PMLR.
  178. [184]Network CGAR. The molecular taxonomy of primary prostate cancer. Cell. 2015;163(4):1011–25. 10.1016/j.cell.2015.10.025. 26544944 PMC4695400 · DOI
  179. [185]Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400-16.e11. 10.1016/j.cell.2018.02.052. 29625055 PMC6066282 · DOI · Paper page
  180. [186]Rajeshkumar NV, Tan AC, De Oliveira E, Womack C, Wombwell H, Morgan S, et al. Antitumor effects and biomarkers of activity of AZD0530, a Src inhibitor, in pancreatic cancer. Clin Cancer Res. 2009;15(12):4138–46. 10.1158/1078-0432.CCR-08-3021. 19509160 · DOI
  181. [187]Chen Z, Zeng Y, Ma P, Xu Q, Zeng L, Song X, et al. Integrated GMPS and RAMP3 as a signature to predict prognosis and immune heterogeneity in hepatocellular carcinoma. Gene. 2025;933: 148958. 10.1016/j.gene.2024.148958. 39312983 · DOI
  182. [188]Xu Q, Ying H, Xie C, Lin R, Huang Y, Zhu R, et al. Characterization of neutrophil extracellular traps related gene pair for predicting prognosis in hepatocellular carcinoma. J Gene Med. 2023;25(11): e3551. 10.1002/jgm.3551. 37401256 · DOI
  183. [189]Huang Y, Xu J, Xie C, Liao Y, Lin R, Zeng Y, et al. A novel gene pair CSTF2/DPE2A impacts prognosis and cell cycle of hepatocellular carcinoma. J Hepatocell Carcinoma. 2023;10:1639–57. 10.2147/JHC.S413935. 37791068 PMC10544262 · DOI
  184. [190]O’Brien KM, Cole SR, Tse C-K, Perou CM, Carey LA, Foulkes WD, et al. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res. 2010;16(24):6100–10. 10.1158/1078-0432.CCR-10-1533. 21169259 PMC3029098 · DOI
  185. [191]Osborne CK, Schiff R. Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer. Breast. 2003;12(6):362–7. 10.1016/s0960-9776(03)00137-1. 14659106 · DOI
  186. [192]Clarke R, Liu MC, Bouker KB, Gu Z, Lee RY, Zhu Y, et al. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene. 2003;22(47):7316–39. 10.1038/sj.onc.1206937. 14576841 · DOI
  187. [193]Lichtner RB. Estrogen/EGF receptor interactions in breast cancer: rationale for new therapeutic combination strategies. Biomed Pharmacother. 2003;57(10):447–51. 10.1016/j.biopha.2003.09.006. 14637387 · DOI
  188. [194]Dowsett M. Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer. Endocr Relat Cancer. 2001;8(3):191–5. 10.1677/erc.0.0080191. 11566610 · DOI
  189. [195]Zeltser L, Desplan C, Heintz N. Hoxb-13: a new Hox gene in a distant region of the HOXB cluster maintains colinearity. Development. 1996;122(8):2475–84. 10.1242/dev.122.8.2475. 8756292 · DOI
  190. [196]Chen H, Xie H, Wang P, Yan S, Zhang Y, Wang G. A 25 immune-related gene pair signature predicts overall survival in cervical cancer. Cancer Inform. 2022;21: 11769351221090921. 10.1177/11769351221090921. 35464777 PMC9021468 · DOI
  191. [197]Jiang Z, Xu J, Zhang S, Lan H, Bao Y. A pairwise immune gene model for predicting overall survival and stratifying subtypes of colon adenocarcinoma. J Cancer Res Clin Oncol. 2023;149(12):10813–29. 10.1007/s00432-023-04957-y. 37316691 PMC11797178 · DOI
  192. [198]Ning Z-k, Tian H-k, Liu J, Hu C-g, Liu Z-t, Li H, et al. Analysis and application of RNA binding protein gene pairs to predict the prognosis of gastric cancer. Heliyon. 2023;9(7): e18242. 10.1016/j.heliyon.2023.e18242. 37539127 PMC10393628 · DOI
  193. [199]Li X, Du G, Li L, Peng K. Cellular specificity of lactate metabolism and a novel lactate-related gene pair index for frontline treatment in clear cell renal cell carcinoma. Front Oncol. 2023;13: 1253783. 10.3389/fonc.2023.1253783. 37795453 PMC10546032 · DOI
  194. [200]Li Y, An L, Jia Z, Li J, Zhou E, Wu F, et al. Identification of ubiquitin-related gene-pair signatures for predicting tumor microenvironment infiltration and drug sensitivity of lung adenocarcinoma. Cancers. 2022;14(14): 3478. 10.3390/cancers14143478. 35884544 PMC9317993 · DOI
  195. [201]Yin Z, Deng J, Zhou M, Li M, Zhou E, Liu J, et al. Exploration of a novel circadian miRNA pair signature for predicting prognosis of lung adenocarcinoma. Cancers. 2022;14(20): 5106. 10.3390/cancers14205106. 36291889 PMC9600995 · DOI
  196. [202]Li K, Wang W. Establishment of m7G-related gene pair signature to predict overall survival in colorectal cancer. Front Genet. 2022;13: 981392. 10.3389/fgene.2022.981392. 36313441 PMC9614021 · DOI
  197. [203]Chen Q, Tang P, Huang H, Qiu X. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer. Front Immunol. 2022;13: 934124. 10.3389/fimmu.2022.934124. 35958575 PMC9357884 · DOI
  198. [204]Cheng L, Wu H, Zheng X, Zhang N, Zhao P, Wang R, et al. GPGPS: a robust prognostic gene pair signature of glioma ensembling IDH mutation and 1p/19q co-deletion. Bioinformatics. 2023;39(1):btac850. 10.1093/bioinformatics/btac850. 36637205 PMC9843586 · DOI
  199. [205]Wang G, Man Y, Cao K, Zhao L, Lun L, Chen Y, et al. An immune-related gene pair signature predicts the prognosis and immunotherapeutic response in glioblastoma. Heliyon. 2024;10(19): e39025. 10.1016/j.heliyon.2024.e39025. 39435104 PMC11492119 · DOI
  200. [206]Huiwen R, Cheng Y, Hongwei S, Hongwei L. Predictive effect of microRNA ratio in osteosarcoma. J Clin Oncol. 2014;41(8):708. 10.3760/cma.j.issn.1673-422X.2014.09.019. · DOI

200 of 222 shown

Cited by

Sorted by citations

Authors
Wu, C., Xie, X., Yang, X., Du, M., Lin, H., & Huang, J.
Affiliations
University of Electronic Science and Technology of China (CN)
Corresponding author
  • Lin, Hao
  • Huang, Jian
Venue
Molecular Biomedicine
Published
2025-04-09
Volume
6
Issue
1
Pages
22-22
ISSN
2662-8651 (ISSN-L)
OpenAlex
W4409286760
Cited by
10
References
5
Citations by year
2026: 9 · 2025: 1
FWCI
0.89
Type
journal article
Language
en
Open access
Locations
  • Molecular Biomedicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (62371112)
  • Medico-Engineering Cooperation Funds from University of Electronic Science and Technology of China (ZYGX2022YGRH004)
  • Incubation Program for Innovative Science and Technology in UESTC (Y03023206100209)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
gene expression data, precision medicine, differential gene expression, rank-based methods, pulmonary tuberculosis, biomarker discovery, disease progression, high-dimensional omics data, classifier construction
MeSH terms
Humans, Computational Biology, Gene Expression Profiling, Biomedical Research, Precision Medicine, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review